残余胆固醇升高可重新分层缺血性心脏病与心肌梗死风险
研究随访41,928名无缺血性心血管病、糖尿病且未用他汀的丹麦白人超过10年,评估残余胆固醇加入传统风险因素模型后的风险重分类效果。结果显示,残余胆固醇≥1.6 mmol/L(61 mg/dL)者中,23%的心肌梗死和21%的缺血性心脏病事件被正确重分类至10年发生率5%以上,无事件被错误重分类,心肌梗死NRI为10%(95%CI:1%-20%),缺血性心脏病NRI为5%(95%CI:-3%至13%)。
要点
- 残余胆固醇≥1.6 mmol/L可正确重分类约23%心梗和21%缺血性心脏病事件。
- 加入残余胆固醇后心梗NRI为10%,缺血性心脏病NRI为5%(无统计学意义)。
- 联合5%、7.5%、10%切点时心梗NRI达20%,缺血性心脏病NRI达11%。
核心结论
- 残余胆固醇升高可显著改善心肌梗死和缺血性心脏病的风险预测与重分类。
研究设计与样本
- 前瞻性队列研究,随访41,928名丹麦白人(哥本哈根普通人群研究),无缺血性心血管病、糖尿病且未用他汀,随访超过10年。
主要发现
- 残余胆固醇≥95百分位(≥1.6 mmol/L,61 mg/dL)者中,23%(P<0.001)的心肌梗死和21%(P<0.001)的缺血性心脏病事件被正确重分类至10年发生率5%以上。
- 无事件被错误重分类,加入残余胆固醇后心肌梗死NRI为10%(95%CI:1%-20%),缺血性心脏病NRI为5%(95%CI:-3%至13%)。
- 联合5%、7.5%、10%风险切点重分类时,42%(P<0.001)的心肌梗死个体和41%(P<0.001)的缺血性心脏病个体被正确重分类,NRI分别为20%(95%CI:9%-31%)和11%(95%CI:2%-21%)。
关键数值与推荐
- 残余胆固醇升高切点:≥95百分位,即≥1.6 mmol/L(61 mg/dL)。
- 10年事件风险重分类切点:5%、7.5%、10%。
- 心肌梗死NRI:10%(95%CI:1%-20%);缺血性心脏病NRI:5%(95%CI:-3%至13%)。
- 联合重分类NRI:心肌梗死20%(95%CI:9%-31%);缺血性心脏病11%(95%CI:2%-21%)。
临床怎么用
- 在传统风险因素评估基础上,可考虑检测残余胆固醇以改善心梗和缺血性心脏病风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated remnant cholesterol causes ischemic heart disease. OBJECTIVES: We tested the hypothesis that the inclusion of elevated remnant cholesterol will lead to appropriate reclassification of individuals who later experience myocardial infarction and ischemic heart disease. METHODS: For >10 years we followed up 41,928 white Danish individuals from the Copenhagen General Population Study without a history of ischemic cardiovascular disease, diabetes, and statin use. Using predefined cut points for elevated remnant cholesterol, we calculated net reclassification index (NRI) from below to above 5%, 7.5%, and/or 10% 10-year occurrence of myocardial infarction and ischemic heart disease defined as a composite of death from ischemic heart disease, myocardial infarction, and coronary revascularization. RESULTS: For individuals with remnant cholesterol levels ≥95th percentile (≥1.6 mmol/L, 61 mg/dL), 23% (P < 0.001) of myocardial infarction and 21% (P < 0.001) of ischemic heart disease were reclassified correctly from below to above 5% for 10-year occurrence when remnant cholesterol levels were added to models based on conventional risk factors, whereas no events were reclassified incorrectly. Consequently, the addition of remnant cholesterol levels yielded NRI of 10% (95% CI: 1%-20%) for myocardial infarction and 5% (95% CI: -3% to 13%) for ischemic heart disease. Correspondingly, when reclassifications were combined from below to above 5%, 7.5%, and 10% risk of events, 42% (P < 0.001) of individuals with myocardial infarction and 41% (P < 0.001) with ischemic heart disease were reclassified appropriately, leading to NRI of respectively 20% (95% CI: 9%-31%) and 11% (95% CI: 2%-21%). CONCLUSIONS: Elevated remnant cholesterol levels considerably improve myocardial infarction and ischemic heart disease risk prediction.
引用
- Doi, Langsted, Nordestgaard, et al. Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction. J Am Coll Cardiol. 2022. PMID: 35710189. doi:10.1016/j.jacc.2022.03.384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。